Tammy Thornton

Tammy Thornton

School of Health and Medical Science, University of Southern Queensland - Springfield Campus, Ipswich, Queensland, Australia
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
TTTammy Thornton
Tammy Thornton
Dean MillsDean Mills
Dean Mills
EBEdward Bliss
Edward Bliss
Impaired cognition is the primary symptom of dementia, which can lead to functional disability and reduced quality of life among an increasingly ageing population. Ageing is associated with increased oxidative stress, chronic low-grade systemic inflammation, and endothelial dysfunction, which reduces cerebrovascular function leading to cognitive decline. Chronic low-grade systemic inflammatory conditions, such as obesity, exacerbate this decline beyond normal ageing and predispose individuals to neurodegenerative diseases, such as dementia. Capsaicin, the major pungent molecule of chilli, has recently demonstrated improvements in cognition in animal models via activation of the transient receptor potential vanilloid channel 1 (TRPV1). Capsaicin-induced TRPV1 activation reduces adiposity, chronic low-grade systemic inflammation, and oxidative stress, as well as improves endothelial function, all of which are associated with cerebrovascular function and cognition. This review examines the current literature on capsaicin and Capsimax, a capsaicin supplement associated with reduced gastrointestinal irritation compared to capsaicin. Acute and chronic capsaicin treatment can improve cognition in animals. However, studies adequately assessing the effects of capsaicin on cerebrovascular function, and cognition in humans do not exist. Capsimax may be a potentially safe therapeutic intervention for future clinical trials testing the effects of capsaicin on cerebrovascular function and cognition.
1

8 December 2023 in Life Sciences
Verified
Journal Article
Open access
TTTammy Thornton
Tammy Thornton
DMDean Mills
Dean Mills
EBEdward Bliss
Edward Bliss
Obesity is a worldwide epidemic coinciding with a concomitant increase in the incidence of neurodegenerative diseases, particularly dementia. Obesity is characterised by increased adiposity, chronic low-grade systemic inflammation, and oxidative stress, which promote endothelial dysfunction. Endothelial dysfunction reduces cerebrovascular function leading to reduced cerebral blood flow and, eventually, cognitive decline, thus predisposing to a neurodegenerative disease. Obesity is also characterised by gut dysbiosis and a subsequent increase in the lipopolysaccharide which increasingly activates toll-like receptor 4 (TLR4) and further promotes chronic low-grade systemic inflammation. This also disrupts the crosstalk within the gut-brain axis, thus influencing the functions of the central nervous system, including cognition. However, the mechanisms by which obesity-related increases in oxidative stress, inflammation and endothelial dysfunction are driven by, or associated with, increased systemic lipopolysaccharide leading to reduced cerebrovascular function and cognition, beyond normal ageing, have not been elucidated. Hence, this review examines how increased concentrations of lipopolysaccharide and the subsequent increased TLR4 activation observed in obesity exacerbate the development of obesity-induced reductions in cerebrovascular function and cognition.

30 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
TTTammy Thornton
Tammy Thornton
EKEmma Yubin Kim
Emma Yubin Kim
TDTahnee Downs
Tahnee Downs
Dean MillsDean Mills
Dean Mills
EBEdward Bliss
Edward Bliss
Background/Objectives: Cerebrovascular function and cognition decline with age and may be further exacerbated by obesity. Capsaicin may improve cerebrovascular function and cognition, although evidence in humans is lacking. We investigated the effects of 12 weeks of capsaicin supplementation on cerebrovascular function and cognition in middle-aged and older adults who were overweight or obese. Methods: Forty participants were randomly allocated to receive 200 mg/day of Capsifen® or a placebo, with 34 completing the intervention (n = 17 in both). Before and after supplementation, transcranial Doppler ultrasonography was used to measure the cerebrovascular responsiveness (CVR) to physiological (hypercapnia, 5% carbon dioxide) and cognitive stimuli, while cognition was assessed using a comprehensive cognitive battery. The trial was prospectively registered (ACTRN12623000556640). Results: Total CVR to cognitive stimuli increased following Capsifen® supplementation (18 ± 3% to 21 ± 1%) and decreased in the placebo group (21 ± 4% to 19 ± 3%; p = 0.0002). Total cognition increased following Capsifen® supplementation (98 ± 18 to 107 ± 18) compared with the placebo (105 ± 13 to 106 ± 10; p = 0.0085). Capsifen® did not alter CVR to hypercapnia (30 ± 18% to 44 ± 27% vs. 39 ± 23% to 32 ± 16%; p = 0.5981). Working memory, executive function and exercise performance also improved, while waist circumference and waist-to-hip ratio decreased. Conclusions: Twelve weeks of Capsifen® supplementation improved total cognition and CVR to cognitive stimuli but not CVR to hypercapnia. These findings provide preliminary evidence that chronic capsaicin supplementation may improve cognition and neurovascular coupling in humans.